Background [ 68 Ga]Ga-NODAGA[40Lys]-Exendin-4 ( 68 Ga-Ex-4) is a new PET radiopharmaceutical targeting GLP-1-R that showed great specificity and sensitivity in the topographic diagnosis of benign insulinoma. We herein report the development of a new method for 68 Ga-Ex-4 radiolabeling in sodium acetate buffer, automated on the miniAllinOne synthesizer. Results Key parameters were reaction volume, due to low amount of peptide, and pH. At a reaction volume of 2.65 and pH 2.9, the reaction yielded 80% of 68 Ga-Ex-4. The use of polysorbate and cooling of the solution allows to decrease the adsorption on the reaction vial (from 29 to 2% of total activity remaining on the vial). 68 Ga-Ex-4 is purified on a HLB cartridge. Final product was obtained within 40 minutes, with a mean radiochemical purity of 97% and a production yield of 67%. Conclusions We have successfully developed a new radiolabeling method for [ 68 Ga]Ga-NODAGA-[40Lys]Exendin-4, automated on a miniAllinOne synthesizer and using sodium acetate buffer, suitable for clinical application.
[68Ga]Ga-NODAGA[40Lys]-Exendin-4 (68Ga-Ex-4) is a new PET radiopharmaceutical targeting GLP-1-R that showed great specificity and sensitivity in the topogr
About Me
Radiopharmacy intern with an interest in analytical chemistry and radiochemistry
Radiopharmacy intern with an interest in analytical chemistry and radiochemistry